Clinical trial
Stiripentol for the Treatment of Refractory Status Epilepticus
NCT06540378 is registered in ClinicalTrials.gov with University Hospital Marburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Stiripentol for the Treatment of Refractory Status Epilepticus
- Lead sponsor
- University Hospital Marburg
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2013
- Completion date
- May 31, 2024
- Enrollment
- 25 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.